Lek (pharmaceutical company)
|The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (March 2017) (Learn how and when to remove this template message)|
|This article is being considered for deletion in accordance with Wikipedia's deletion policy.|
Please share your thoughts on the matter at this article's entry on the Articles for deletion page.
Feel free to edit the article, but the article must not be blanked, and this notice must not be removed, until the discussion is closed. For more information, particularly on merging or moving the article during the discussion, read the guide to deletion.
Unregistered users placing this tag on an article cannot complete the deletion nomination and should leave detailed reasons for deletion on Talk:Lek (pharmaceutical company) and then post a message at Wikipedia talk:Articles for deletion requesting that someone else complete the process. If the nomination is not completed and no message is left on the talkpage, this tag may be removed.
Lek is an international pharmaceutical company, now part of Sandoz, originally established 1946 in Slovenia. Lek and Krka are two major regional pharmaceutical companies, representing an important part of Slovenian export.
In Mengeš, runs a biopharmaceutical center, which is one of Sandoz's key development centers. Lek closely cooperates with scientific institutions in Slovenia, including Jožef Stefan Institute, National Institute of Chemistry, and several Slovenian universities.
Important markets of Lek include the United States, Russia, and Poland.
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|
|30px||This corporation or company article is a stub. You can help Wikipedia by expanding it.|